This narrative review will explore the compelling rationale for investigating the GLP-1 system in BED, detailing its biological basis and analyzing the promising therapeutic evidence from preclinical and clinical studies. The gene discussed is GCG; the disease is X-linked cone dysfunction syndrome with myopia.